An inside look at this revolutionary field of medicine
EXPLORE TRACKER
STAT's Obesity Drug Tracker captures the progress of dozens of new weight loss drugs in development or on the market, including obesity medications being cultivated by industry leaders Eli Lilly and Novo Nordisk.
Our newest data tool breaks down the latest updates each quarter to give you an inside look at what new mechanisms could hit the market, which companies are running the most trials, and other need-to-know details about this revolutionary field of medicine.
Subscribe to STAT+ to get access the tracker.
EXPLORE TRACKER
No comments